Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AXNX vs $NMTC | Chartloom

Compare

$AXNX vs $NMTC

Axonics Inc · NeuroOne Medical Technologies Corp

AXNX

Axonics Inc

NMTC

NeuroOne Medical Technologies Corp

Compare $AXNX vs $NMTC

Comparing Axonics Inc and NeuroOne Medical Technologies Corp

AXNXAxonics Inc

NMTCNeuroOne Medical Technologies Corp

AXNXAxonics Inc

Market cap

$36M

P/E (TTM)

—

Forward P/E (NTM)

1.40x

Forward P/S (NTM)

0.07x

Rev growth (TTM)

26.1%

YTD performance

-0.1%

52W performance

-98.8%

FCF yield

14.8%

NMTCNeuroOne Medical Technologies Corp

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.76x

Rev growth (TTM)

3.8%

YTD performance

-78.5%

52W performance

-80.7%

FCF yield

-74.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AXNX

NMTC

Not enough overlapping price history for this window.

Detailed metrics comparison

AXNX

Axonics Inc

NMTC

NeuroOne Medical Technologies Corp

Market Cap

AXNX$36M

NMTC$10M

Enterprise Value

AXNX$-203M

NMTC$8M

Price

AXNX$0.71

NMTC$1.10

P/E Ratio

AXNXN/A

NMTCN/A

P/S Ratio

AXNX0.08x

NMTC0.96x

EV/Sales

AXNX-0.47x

NMTC0.75x

EV/EBITDA

AXNX-58.64x

NMTC0.00x

P/B Ratio

AXNX0.02x

NMTC2.71x

P/FCF Ratio

AXNX6.75x

NMTCN/A

EV/FCF

AXNX-37.80x

NMTC-1.05x

PEG Ratio

AXNXN/A

NMTCN/A

Forward P/E (NTM)

AXNX1.40x

NMTCN/A

Forward P/S (NTM)

AXNX0.07x

NMTC0.76x

Revenue (TTM)

AXNX$432M

NMTC$10M

Revenue Growth (YoY)

AXNX26.1%

NMTC3.8%

Forward Rev Growth

AXNX0.0%

NMTC57.3%

Gross Margin (TTM)

AXNX76.6%

NMTC55.7%

Operating Margin (TTM)

AXNX0.0%

NMTC0.0%

EBITDA Margin (TTM)

AXNX1.2%

NMTC-73.7%

Net Margin (TTM)

AXNX-1.3%

NMTC-71.5%

FCF Margin (TTM)

AXNX1.2%

NMTC-71.6%

Net Income (TTM)

AXNX$-6M

NMTC$-7M

FCF (TTM)

AXNX$5M

NMTC$-7M

EPS (TTM)

AXNX-$0.11

NMTC-$0.83

ROE (TTM)

AXNX-88.0%

NMTC-12645.0%

ROA (TTM)

AXNX-77.0%

NMTC-8558.0%

ROIC (TTM)

AXNX-88.0%

NMTC-12645.0%

Cash

AXNX$239M

NMTC$2M

Debt

AXNX$0

NMTC$0

Net Cash/Debt

AXNX$239M

NMTC$2M

Current Ratio (TTM)

AXNX8.16x

NMTC2.84x

Quick Ratio (TTM)

AXNX6.33x

NMTC1.56x

Debt/Equity (TTM)

AXNX0.00x

NMTC0.00x

Debt/Assets (TTM)

AXNX0.0%

NMTC0.0%

Interest Coverage (TTM)

AXNXN/A

NMTCN/A

Net Debt/EBITDA (TTM)

AXNX0.00x

NMTC0.00x

Beta

AXNX3.24

NMTC0.92

52W Performance

AXNX-98.8%

NMTC-80.7%

YTD Performance

AXNX-0.1%

NMTC-78.5%

% from 52W High

AXNX-99.0%

NMTC-82.0%

% from 52W Low

AXNX1.4%

NMTC14.4%

Asset Turnover (TTM)

AXNX0.58x

NMTC1.20x

FCF Yield (TTM)

AXNX14.8%

NMTC-74.8%

Earnings Yield (TTM)

AXNX-15.6%

NMTC-74.7%

Dividend Yield (TTM)

AXNXN/A

NMTCN/A

Rule of 40

AXNX27.3

NMTC-67.8

EV/GP/RG

AXNXN/A

NMTC0.05

Ticker research

View AXNX research View NMTC research

Metric	AXNX Axonics Inc	NMTC NeuroOne Medical Technologies Corp
Market & Valuation
Market Cap	$36M	$10M
Enterprise Value	$-203M	$8M
Price	$0.71	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	0.08x	0.96x
EV/Sales	-0.47x	0.75x
EV/EBITDA	-58.64x	0.00x
P/B Ratio	0.02x	2.71x
P/FCF Ratio	6.75x	N/A
EV/FCF	-37.80x	-1.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1.40x	N/A
Forward P/S (NTM)	0.07x	0.76x
Revenue & Growth
Revenue (TTM)	$432M	$10M
Revenue Growth (YoY)	26.1%	3.8%
Forward Rev Growth	0.0%	57.3%
Profitability
Gross Margin (TTM)	76.6%	55.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	1.2%	-73.7%
Net Margin (TTM)	-1.3%	-71.5%
FCF Margin (TTM)	1.2%	-71.6%
Net Income (TTM)	$-6M	$-7M
FCF (TTM)	$5M	$-7M
EPS (TTM)	-$0.11	-$0.83
ROE (TTM)	-88.0%	-12645.0%
ROA (TTM)	-77.0%	-8558.0%
ROIC (TTM)	-88.0%	-12645.0%
Financial Health
Cash	$239M	$2M
Debt	$0	$0
Net Cash/Debt	$239M	$2M
Current Ratio (TTM)	8.16x	2.84x
Quick Ratio (TTM)	6.33x	1.56x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.24	0.92
52W Performance	-98.8%	-80.7%
YTD Performance	-0.1%	-78.5%
% from 52W High	-99.0%	-82.0%
% from 52W Low	1.4%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	1.20x
FCF Yield (TTM)	14.8%	-74.8%
Earnings Yield (TTM)	-15.6%	-74.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	27.3	-67.8
EV/GP/RG	N/A	0.05
Ticker research	View AXNX research	View NMTC research

Valuation

P/S Ratio

AXNX

0.08x

NMTC

0.96x

EV/FCF

AXNX

-37.80x

NMTC

-1.05x

Growth & revenue

Revenue Growth TTM

AXNX

26.1%

NMTC

3.8%

Forward Revenue Growth

NMTC

57.3%

AXNX

0.0%

Profitability & performance

Gross Margin

AXNX

76.6%

NMTC

55.7%

ROE

AXNX

-88.0%

NMTC

-12645.0%

FCF Yield %

AXNX

14.8%

NMTC

-74.8%

52-Week Performance

NMTC

-80.7%

AXNX

-98.8%

Detailed metrics comparison

AXNX

Axonics Inc

NMTC

NeuroOne Medical Technologies Corp

Market Cap

AXNX$36M

NMTC$10M

Enterprise Value

AXNX$-203M

NMTC$8M

Price

AXNX$0.71

NMTC$1.10

P/E Ratio

AXNXN/A

NMTCN/A

P/S Ratio

AXNX0.08x

NMTC0.96x

EV/Sales

AXNX-0.47x

NMTC0.75x

EV/EBITDA

AXNX-58.64x

NMTC0.00x

P/B Ratio

AXNX0.02x

NMTC2.71x

P/FCF Ratio

AXNX6.75x

NMTCN/A

EV/FCF

AXNX-37.80x

NMTC-1.05x

PEG Ratio

AXNXN/A

NMTCN/A

Forward P/E (NTM)

AXNX1.40x

NMTCN/A

Forward P/S (NTM)

AXNX0.07x

NMTC0.76x

Revenue (TTM)

AXNX$432M

NMTC$10M

Revenue Growth (YoY)

AXNX26.1%

NMTC3.8%

Forward Rev Growth

AXNX0.0%

NMTC57.3%

Gross Margin (TTM)

AXNX76.6%

NMTC55.7%

Operating Margin (TTM)

AXNX0.0%

NMTC0.0%

EBITDA Margin (TTM)

AXNX1.2%

NMTC-73.7%

Net Margin (TTM)

AXNX-1.3%

NMTC-71.5%

FCF Margin (TTM)

AXNX1.2%

NMTC-71.6%

Net Income (TTM)

AXNX$-6M

NMTC$-7M

FCF (TTM)

AXNX$5M

NMTC$-7M

EPS (TTM)

AXNX-$0.11

NMTC-$0.83

ROE (TTM)

AXNX-88.0%

NMTC-12645.0%

ROA (TTM)

AXNX-77.0%

NMTC-8558.0%

ROIC (TTM)

AXNX-88.0%

NMTC-12645.0%

Cash

AXNX$239M

NMTC$2M

Debt

AXNX$0

NMTC$0

Net Cash/Debt

AXNX$239M

NMTC$2M

Current Ratio (TTM)

AXNX8.16x

NMTC2.84x

Quick Ratio (TTM)

AXNX6.33x

NMTC1.56x

Debt/Equity (TTM)

AXNX0.00x

NMTC0.00x

Debt/Assets (TTM)

AXNX0.0%

NMTC0.0%

Interest Coverage (TTM)

AXNXN/A

NMTCN/A

Net Debt/EBITDA (TTM)

AXNX0.00x

NMTC0.00x

Beta

AXNX3.24

NMTC0.92

52W Performance

AXNX-98.8%

NMTC-80.7%

YTD Performance

AXNX-0.1%

NMTC-78.5%

% from 52W High

AXNX-99.0%

NMTC-82.0%

% from 52W Low

AXNX1.4%

NMTC14.4%

Asset Turnover (TTM)

AXNX0.58x

NMTC1.20x

FCF Yield (TTM)

AXNX14.8%

NMTC-74.8%

Earnings Yield (TTM)

AXNX-15.6%

NMTC-74.7%

Dividend Yield (TTM)

AXNXN/A

NMTCN/A

Rule of 40

AXNX27.3

NMTC-67.8

EV/GP/RG

AXNXN/A

NMTC0.05

Ticker research

View AXNX research View NMTC research

Metric	AXNX Axonics Inc	NMTC NeuroOne Medical Technologies Corp
Market & Valuation
Market Cap	$36M	$10M
Enterprise Value	$-203M	$8M
Price	$0.71	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	0.08x	0.96x
EV/Sales	-0.47x	0.75x
EV/EBITDA	-58.64x	0.00x
P/B Ratio	0.02x	2.71x
P/FCF Ratio	6.75x	N/A
EV/FCF	-37.80x	-1.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1.40x	N/A
Forward P/S (NTM)	0.07x	0.76x
Revenue & Growth
Revenue (TTM)	$432M	$10M
Revenue Growth (YoY)	26.1%	3.8%
Forward Rev Growth	0.0%	57.3%
Profitability
Gross Margin (TTM)	76.6%	55.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	1.2%	-73.7%
Net Margin (TTM)	-1.3%	-71.5%
FCF Margin (TTM)	1.2%	-71.6%
Net Income (TTM)	$-6M	$-7M
FCF (TTM)	$5M	$-7M
EPS (TTM)	-$0.11	-$0.83
ROE (TTM)	-88.0%	-12645.0%
ROA (TTM)	-77.0%	-8558.0%
ROIC (TTM)	-88.0%	-12645.0%
Financial Health
Cash	$239M	$2M
Debt	$0	$0
Net Cash/Debt	$239M	$2M
Current Ratio (TTM)	8.16x	2.84x
Quick Ratio (TTM)	6.33x	1.56x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.24	0.92
52W Performance	-98.8%	-80.7%
YTD Performance	-0.1%	-78.5%
% from 52W High	-99.0%	-82.0%
% from 52W Low	1.4%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	1.20x
FCF Yield (TTM)	14.8%	-74.8%
Earnings Yield (TTM)	-15.6%	-74.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	27.3	-67.8
EV/GP/RG	N/A	0.05
Ticker research	View AXNX research	View NMTC research